Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener

Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2019-02-19
NRCNational Research CorpK/i/e Trust Under Agreement 10/24/1810%S - Sale$40.01-89,0255,067,037-2%-$3,561,542
D
2019-02-19
CRLCharles River Laboratories International IncChubb Stephen DDirS - Sale+OE$141.23-4,54034,328-12%-$641,191
M
2019-02-14
EXELExelixis, Inc.Cohen CharlesDirS - Sale$22.14-248,1800-100%-$5,494,906
D
2019-02-14
IQVIqvia Holdings Inc.Rittenmeyer Ronald ADirS - Sale+OE$138.00-7,68059,307-11%-$1,059,840
D
2019-02-14
IQVIqvia Holdings Inc.Bousbib AriSee RemarksS - Sale+OE$140.00-96,0001,273,439-7%-$13,440,000
2019-02-15
NRCNational Research CorpK/i/e Trust Under Agreement 10/24/1810%S - Sale$40.04-11,8485,156,0620%-$474,341
D
2019-02-14
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$22.39-40,000301,499-12%-$895,654
DM
2019-02-14
EXELExelixis, Inc.Schwab GiselaPres, Prod Dev, Med Aff, CMOS - Sale+OE$21.76-123,000331,157-27%-$2,676,600
D
2019-02-14
EXELExelixis, Inc.Feldbaum Carl BDirS - Sale+OE$22.03-50,5008,521-86%-$1,112,515
2019-02-13
BUDZWeed, Inc.Breen Nicole MSecretary, Treasurer, 10%S - Sale$1.46-4,00024,748,7850%-$5,840
D
2019-02-13
SYNHSyneos Health, Inc.Macdonald AlistairCEOS - Sale+OE$53.00-8,143224,004-4%-$431,579
2019-02-11
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale$21.30-1,000128,919-1%-$21,300
2019-02-12
BUDZWeed, Inc.Breen Nicole MSecretary, Treasurer, 10%S - Sale$1.47-3,70024,752,7850%-$5,423
M
2019-02-05
BUDZWeed, Inc.Breen Nicole MSecretary, Treasurer, 10%S - Sale$1.54-22,50024,756,4850%-$34,550
D
2019-02-05
IQVIqvia Holdings Inc.Rittenmeyer Ronald ADirS - Sale+OE$130.00-3,84059,307-6%-$499,200
D
2019-02-05
SYNHSyneos Health, Inc.Macdonald AlistairCEOS - Sale+OE$53.04-6,697224,004-3%-$355,202
M
2019-01-29
BUDZWeed, Inc.Breen Nicole MSecretary, Treasurer, 10%S - Sale$1.58-38,20024,778,9850%-$60,478
D
2019-02-01
INCYIncyte CorpSwain Paula JEVP, HRS - Sale+OE$81.19-10,00031,124-24%-$811,900
M
2019-02-01
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$65.72-103,0138,364,827-1%-$6,770,392
M
2019-02-01
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$65.72-103,0137,751,125-1%-$6,770,392
2019-01-31
NRCNational Research CorpK/i/e Trust Under Agreement 10/24/1810%S - Sale$40.01-2,0735,167,9100%-$82,941
2019-02-01
EXELExelixis, Inc.Scangos George ADirS - Sale$23.53-40,0001,386,626-3%-$941,200
D
2019-01-30
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$23.12-40,000301,447-12%-$924,800
M
2019-01-29
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$63.59-172,3118,467,840-2%-$10,957,446
M
2019-01-29
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$63.59-172,3117,854,138-2%-$10,957,446
M
2019-01-23
BUDZWeed, Inc.Breen Nicole MSecretary, Treasurer, 10%S - Sale$1.50-15,95024,942,1850%-$23,865
2019-01-28
INCYIncyte CorpFlannelly Barry PEVP, GM USS - Sale$80.00-1,0008,944-10%-$80,000
M
2019-01-24
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$61.12-35,6808,640,1510%-$2,180,774
M
2019-01-24
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$61.12-35,6808,026,4490%-$2,180,774
M
2019-01-24
NRCNational Research CorpK/i/e Trust Under Agreement 10/24/1810%S - Sale$40.01-9,7305,169,9830%-$389,290
D
2019-01-24
EXASExact Sciences CorpElliott Jeffrey ThomasCFOS - Sale+OE$78.90-90,90933,992-73%-$7,172,548
D
2019-01-24
EXASExact Sciences CorpCoward D ScottChief Administrative OfficerS - Sale+OE$78.21-169,10982,652-67%-$13,226,226
D
2019-01-25
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$81.27-304,397976,787-24%-$24,737,400
M
2019-01-22
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.00-37,5605,179,713-1%-$1,502,465
AM
2019-01-15
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$61.34-16,5828,748,2450%-$1,017,108
M
2019-01-18
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$61.31-72,4148,675,831-1%-$4,440,040
M
2019-01-18
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$61.31-72,4148,062,129-1%-$4,440,040
2019-01-18
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.07-147,6935,217,273-3%-$5,918,561
D
2019-01-17
INCYIncyte CorpWenqing YaoEVP, Head of Discovery ChemS - Sale+OE$77.61-15,35434,409-31%-$1,191,624
D
2019-01-16
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$23.29-40,000301,398-12%-$931,456
M
2019-01-15
MEDPMedpace Holdings, Inc.Troendle August J.Pres, CEO, 10%S - Sale$61.34-16,5828,748,2450%-$1,017,108
M
2019-01-15
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$61.34-16,5828,134,5430%-$1,017,108
D
2019-01-15
INCYIncyte CorpTrower PaulPrincipal Accounting OfficerS - Sale+OE$75.00-5,81313,900-29%-$435,975
M
2019-01-11
HSGXHistogenics CorpKirk Randal J10%S - Sale$0.16-998,2041,692,366-37%-$158,772
D
2019-01-10
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale+OE$23.85-3,000129,833-2%-$71,540
2019-01-08
INCYIncyte CorpFlannelly Barry PEVP, GM USS - Sale$75.56-1,7149,944-15%-$129,510
2019-01-08
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$115.00-25,000289,501-8%-$2,875,000
DM
2019-01-07
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale+OE$22.18-9,120130,833-7%-$202,280
D
2019-01-08
EXELExelixis, Inc.Garber Alan MDirS - Sale+OE$23.00-11,25061,329-16%-$258,750
D
2019-01-07
INCYIncyte CorpWenqing YaoEVP, Head of Discovery ChemS - Sale+OE$75.00-10,00034,409-23%-$750,000
D
2019-01-07
INCYIncyte CorpTrower PaulPrincipal Accounting OfficerS - Sale+OE$75.00-9,18713,900-40%-$689,025
D
2019-01-04
INCYIncyte CorpSwain Paula JEVP, HRS - Sale+OE$70.00-30,00031,124-49%-$2,100,000
DM
2019-01-02
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$20.11-40,000301,352-12%-$804,254
M
2019-01-02
EXELExelixis, Inc.Scangos George ADirS - Sale$19.64-40,0001,426,626-3%-$785,635
D
2019-01-03
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale+OE$19.95-8,000130,833-6%-$159,600
D
2019-01-03
XONIntrexon CorpLehr Donald P.GCS - Sale+OE$7.07-3,83234,183-10%-$27,094
D
2019-01-03
XONIntrexon CorpPerez Jeffrey ThomasSVP, IP AffairsS - Sale+OE$7.07-3,51418,789-16%-$24,846
D
2019-01-03
XONIntrexon CorpReed Thomas D.Chief Science OfficerS - Sale+OE$7.07-2,94479,537-4%-$20,816
D
2019-01-03
XONIntrexon CorpSabzevari HelenPres, Precigen, Inc.S - Sale+OE$7.07-3,83222,532-15%-$27,094
D
2019-01-03
XONIntrexon CorpSterling Rick L.CFOS - Sale+OE$7.07-3,51480,873-4%-$24,846
D
2019-01-03
XONIntrexon CorpWalsh Robert F. IIISVP, Energy, Fine Chem.S - Sale+OE$7.07-4,0585,708-42%-$28,692
D
2019-01-04
XONIntrexon CorpLiffman Joel DSVP, FinanceS - Sale+OE$7.03-3,72585,541-4%-$26,187
D
2019-01-03
XONIntrexon CorpNimrodi NirChief Business OfficerS - Sale+OE$7.07-4,05813,077-24%-$28,692
D
2019-01-03
EXASExact Sciences CorpCoward D ScottChief Administrative OfficerS - Sale+OE$62.75-1,58182,652-2%-$99,214
2018-12-31
XONIntrexon CorpReed Thomas D.Chief Science OfficerS - Sale$6.36-30,00072,715-29%-$190,671
2018-12-17
SYNHSyneos Health, Inc.Olefson JonathanGC, Corp SectyP - Purchase$41.27+75011,314+7%+$30,955
2018-12-17
SYNHSyneos Health, Inc.Meggs Jason M.CFOP - Purchase$41.25+3,65038,265+11%+$150,563
2018-12-17
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.00-1,3595,364,9660%-$54,360
2018-12-13
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.00-2,0135,366,3250%-$80,520
2018-12-12
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.00-4,4065,368,3380%-$176,245
2018-12-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$129.11-1,977314,501-1%-$255,252
2018-12-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$127.47-3,668291,416-1%-$467,555
2018-12-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$126.73-3,981299,204-1%-$504,523
2018-12-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$126.41-4,308303,185-1%-$544,567
2018-12-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$128.25-3,668287,748-1%-$470,416
2018-12-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale$127.10-4,120295,084-1%-$523,650
D
2018-12-10
CRLCharles River Laboratories International IncFoster James CCOB, Pres, CEOS - Sale+OE$126.05-3,401336,223-1%-$428,690
2018-12-04
IQVIqvia Holdings Inc.Connaughton JohnDirS - Sale$123.72-767,5742,971,054-21%-$94,964,255
2018-12-03
IQVIqvia Holdings Inc.McDonnell Michael REVP, CFOS - Sale$128.35-9,50028,785-25%-$1,219,325
2018-12-04
IQVIqvia Holdings Inc.Tpg Group Holdings (Sbs) Advisors, Inc.DirS - Sale$123.72-3,573,54512,575,731-22%-$442,118,987
2018-12-04
CRLCharles River Laboratories International IncBertolini Robert JDirS - Sale$134.71-1,10025,336-4%-$148,179
D
2018-12-04
CRLCharles River Laboratories International IncBertolini Robert JDirS - Sale+OE$133.77-3,44026,436-12%-$460,154
2018-12-04
IQVIqvia Holdings Inc.Canada Pension Plan Investment Board10%S - Sale$123.72-3,164,3885,912,172-35%-$391,498,083
M
2018-11-29
EXELExelixis, Inc.Scangos George ADirS - Sale$20.84-55,0001,480,576-4%-$1,146,400
D
2018-12-03
EXELExelixis, Inc.Schwab GiselaPres, Prod Dev, Med Aff, CMOS - Sale+OE$21.02-13,499331,018-4%-$283,749
2018-11-29
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.01-4,4415,372,7440%-$177,699
M
2018-11-28
EXELExelixis, Inc.Hessekiel JeffreyEVP, GCS - Sale$19.25-14,818234,437-6%-$285,290
2018-11-30
EXELExelixis, Inc.Senner Christopher J.EVP, CFOS - Sale$19.70-8,791149,300-6%-$173,183
2018-11-28
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.00-2,6405,377,1850%-$105,600
D
2018-11-15
EXELExelixis, Inc.Morrissey MichaelPres, CEOS - Sale+OE$17.22-25,000301,352-8%-$430,500
D
2018-11-12
EXASExact Sciences CorpZanotti Katherine SDirS - Sale+OE$69.00-7,667102,102-7%-$529,023
D
2018-11-12
EXASExact Sciences CorpConroy Kevin TPres, CEOS - Sale+OE$69.00-163,514976,780-14%-$11,282,466
2018-11-12
CRLCharles River Laboratories International IncSmith David RossCorporate EVP, CFOS - Sale$134.49-1,86610,575-15%-$250,961
2018-11-12
NRCNational Research CorpK/i/e/trust Under Agreement 3/9/0910%S - Sale$40.00-2,1735,379,8250%-$86,920
2018-11-07
EXELExelixis, Inc.Haley Patrick J.SVP, CommercialS - Sale$17.32-20,000138,739-13%-$346,400
2018-11-08
INCYIncyte CorpBienaime Jean JacquesDirP - Purchase$68.77+1,0006,668+18%+$68,765
D
2018-11-07
CRLCharles River Laboratories International IncJohst David PCorporate EVPS - Sale+OE$136.00-23,356196,493-11%-$3,176,416
M
2018-11-05
EXASExact Sciences CorpLidgard Graham PeterChief Science OfficerS - Sale$75.01-38,31141,040-48%-$2,873,633
D
2018-11-01
EXELExelixis, Inc.Schwab GiselaPres, Prod Dev, Med Aff, CMOS - Sale+OE$14.16-12,000342,793-3%-$169,920
2018-11-01
EXELExelixis, Inc.Scangos George ADirS - Sale$14.66-25,0001,535,576-2%-$366,400
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top